All Three Leading Independent Proxy Advisory Firms Support All Xperi Board Candidates
Egan-Jones Joins ISS and Glass Lewis in Recommending Stockholders Vote “FOR” All Xperi Board Nominees on the BLUE Proxy Card Xperi Encourages Stockholders to... Read more.
Advyzon Investment Management (AIM) Adds New Asset Managers, Including BlackRock and DFA
TAMP now has over 280 strategies from 46 asset managers CHICAGO–(BUSINESS WIRE)–#CRM—Advyzon Investment Management (AIM), a turnkey asset management... Read more.
eDreams ODIGEO Recognized by Forbes as One of the ‘Best Companies to Work for 2024’ for Third Consecutive Year
BARCELONA, Spain–(BUSINESS WIRE)–eDreams ODIGEO (hereinafter, ‘the Company’ or ‘eDO’ for short), the world’s leading travel subscription company... Read more.
UL Solutions Joins Forces with Efectis Era Avrasya to Help Manufacturers Advance Fire Door Safety in Southeast Europe and the Middle East
The collaboration between UL Solutions and Efectis Era Avrasya supports regional fire door manufacturers facing growing demand, helping them build trust with their... Read more.
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
VE303 is an orally administered, potential first-in-class live biotherapeutic product candidate being developed to prevent recurrence of Clostridioides difficile... Read more.
Anumana Demonstrates Global Readiness with Receipt of ISO 13485 Certification
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#AI—Anumana, a leading AI-driven health technology company and portfolio company of nference, announced today... Read more.
New Eptura Research Reveals Employee-Led Hybrid Work Models and Connected Technology Drive Highest Return
Workplace Index report finds leaders project an average 3-8% incremental revenue increase to effective office use for hybrid work ATLANTA–(BUSINESS WIRE)–Eptura,... Read more.
Leading Pharmaceutical Company Selects Kinaxis to Cure Supply Chain Headaches
Kinaxis to drive supply chain efficiencies for Servier’s targeted portfolio of lifesaving drugs OTTAWA, Ontario–(BUSINESS WIRE)–Kinaxis® Inc. (TSX:... Read more.
Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
Updated Prescription Drug User Fee Act (PDUFA) goal date of December 29, 2024 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CheckMate—Bristol Myers Squibb... Read more.
CI Financial Reports Total Assets of $467.9 Billion for April 2024
All financial amounts in Canadian dollars unless stated otherwise. TORONTO–(BUSINESS WIRE)–$CIX #CIFinancial—CI Financial Corp. (“CI”) (TSX:... Read more.